<!DOCTYPE html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />

    <title>Study Design</title>

    <link rel="stylesheet" href="assets/css/bootstrap.min.css" />
    <link rel="stylesheet" href="assets/css/all.min.css" />
    <link rel="stylesheet" href="assets/css/owl.carousel.min.css" />
    <link rel="stylesheet" href="assets/css/style.css" />
  </head>
  <body class="vertical-bg">
    
     <!-- start header section -->
     <header id="header-section">
      <div class="header-top">
        <div
          class="
            container
            d-sm-flex
            flex-wrap flex-md-nowrap
            text-center
            justify-content-center justify-content-md-between
            align-items-center
          "
        >
          <p class="tg-regular mb-0 mt-1 mt-sm-0 me-auto">
            For Canadian residents only
          </p>
          <a href="safty-profile.html" class="c-darkblue tg-bold-20"
            >Safety Information & References</a
          >
          <a href="safty-profile.html" class="c-darkblue tg-bold-20"
            >Product Monograph</a
          >
          <a href="#" class="mb-1 mb-sm-0">
            <img src="assets/images/top-logo.png" alt="" />
          </a>
        </div>
      </div>
      <div class="header-main tg-bold-20">
        <div
          class="
            container
            d-flex
            flex-wrap
            align-items-center
            justify-content-between
          "
        >
          <a href="/" class="logo">
            <img src="assets/images/logo.png" alt="" />
          </a>
          <i class="fas fa-bars d-lg-none"></i>
          <nav class="text-uppercase d-lg-flex align-items-center">
            <ul class="d-lg-flex">
              <li><a href="home.html">Home</a></li>
              <li><a href="study-design.html">Study Designs</a></li>
              <li><a href="efficacy-1.html">Efficacy Data</a></li>
              <li><a href="safety-profile.html">Safety Profile</a></li>
              <li><a href="moa.html">MOA</a></li>
              <li>
                <a class="active" href="dosing-administration.html">Dosing & Administration</a>
              </li>
              <li><a href="resources.html">Resources</a></li>
              <li><a href="isi-reference-2.html">Coverage</a></li>
            </ul>
            <a href="#">EN <i class="fas fa-angle-up"></i></a>
          </nav>
        </div>
      </div>
    </header>
    <!-- end header section -->

    <!-- start dosing-administration section -->
    <section id="dosing-administration" class="mt-5 pt-lg-4">
      <div class="da-top">
        <div class="container text-center">
          <div>
            <h2 class="big-title mb-4 pb-lg-3">
              LIBTAYO dosing protocol <sup>1</sup>
            </h2>
            <img src="assets/images/dosing-administration.png" alt="" />
            <div class="green-border mt-4 pt-lg-4">
              <p class="tg-bold c-darkblue">
                Treatment may be continued until symptomatic <br />
                disease progression or unacceptable toxicity.
              </p>
            </div>
          </div>
          <div class="text-start">
            <p>
              In patients with a low body weight, a dose of 3 mg/kg every two
              weeks administered as an IV infusion over 30 minutes may be
              considered.
            </p>
            <p>
              No dose reductions are recommended. Dosing delay or
              discontinuation may be required based on individual safety and
              tolerability.
            </p>
            <p>
              Please see the Product Monograph for completing dosing and
              administration recommendations.
            </p>
            <p class="mt-4 pt-lg-3 pb-lg-5 pb-4">IV: intravenous.</p>
          </div>
        </div>
      </div>
      <div class="da-preparation">
        <div class="container py-lg-5 py-4 mt-4 mt-lg-5">
          <h2 class="big-title mb-4 pb-lg-3">
            Preparation of LIBTAYO<sup>1</sup>
          </h2>
          <div class="d-flex flex-wrap flex-xl-nowrap">
            <div class="dap-left">
              <div>
                <h4 class="tg-bold">
                  1. Visually inspect the drug product for particulate matter
                  and discolouration prior to administration.
                </h4>
                <ul class="pink-bullet-list ps-3">
                  <li>
                    Libtayo is a clear to slightly opalescent, colorless to pale
                    yellow solution that may contain trace amounts of
                    translucent to white particles
                  </li>
                  <li>
                    Discard the vial if the solution is cloudy, discolored or
                    contains extraneous particulate matter other than trace
                    amounts of translucent-to-white particles
                  </li>
                  <li>Do not shake the vial</li>
                </ul>
              </div>
              <div>
                <h4 class="tg-bold">
                  2. Withdraw the required volume from the vial(s) of LIBTAYO
                  and transfer into an intravenous (IV) infusion bag containing
                  0.9% Sodium Chloride Injection or 5% Dextrose Injection.
                </h4>
              </div>
              <div>
                <h4 class="tg-bold">
                  3. Mix the diluted solution by gentle inversion.
                </h4>
                <ul class="pink-bullet-list ps-3">
                  <li>Do not shake the solution</li>
                  <li>
                    The final concentration of the diluted solution should be
                    between 1 mg/mL to 20 mg/mL
                  </li>
                </ul>
              </div>
            </div>
            <div class="dap-right mx-auto ms-xl-">
              <img src="assets/images/libatayo-bottle.png" alt="" />
            </div>
          </div>
          <p class="mt-4 mt-xl-0">
            LIBTAYO is for single use only. Dispose of any unused medicinal
            product or waste material in accordance with local requirements.
          </p>

          <p>
            No compatibility studies have been performed. Do not mix with other
            medicinal products.
          </p>
        </div>
      </div>
      <div class="da-administration py-4 py-lg-5 mt-lg-3">
        <div class="container">
          <h2 class="big-title text-center mb-4">
            Administration of LIBTAYO <sup>1</sup>
          </h2>
          <div>
            <h4 class="tg-bold mb-3">
              LIBTAYO must be administered by intravenous infusion over 30
              minutes through an intravenous line containing a sterile in-line
              or add-on filter (0.2-micron to 5-micron pore size)
            </h4>
            <ul class="pink-bullet-list">
              <li>
                Do not co-administer with other drugs through the same infusion
                line
              </li>
            </ul>
          </div>
        </div>
      </div>
      <div class="da-preparation da-storage mb-lg-5">
        <div class="container py-lg-5 py-4 mt-lg-4">
          <h2 class="big-title mb-4 pb-lg-3">Storage of LIBTAYO<sup>1</sup></h2>
          <div>
            <p>
              Once prepared, administer the diluted solution immediately. If
              diluted solution is not administered immediately, it may be stored
              temporarily either:
            </p>
            <ul class="pink-bullet-list">
              <li>
                At room temperature up to 25°C for no more than 8 hours from the
                time of preparation. This includes room temperature storage of
                the infusion solution in the IV container and time for
                administration of the infusion.
              </li>
              <span class="my-3 d-block"> or </span>
              <li>
                Under refrigeration at 2°C to 8°C for no more than 24 hours from
                the time of infusion preparation. Allow the diluted solution to
                come to room temperature prior to administration.
              </li>
              <br />
              <li>Do not freeze</li>
              <li>Do not shake</li>
            </ul>
          </div>
        </div>
      </div>
    </section>
    <!-- end dosing-administration section -->

    <section id="section-items" class="mb-4 mb-lg-5">
        <div class="section-item">
          <div class="container">
            <div class="si-item">
              <img src="assets/images/safty-profile.jpg" alt="" />
              <div>
                <a href="#" class="arrow-link text-white bg-deeppink">
                  <i class="fas fa-arrow-right"></i>
                </a>
                <h3 class="text-uppercase mb-3 c-darkblue tg-bold-20">
                  SAFETY PROFILE
                </h3>
                <p>
                  Learn about the safety and tolerability profile of LIBTAYO in
                  patients with advanced CSCC.
                </p>
                <a
                  href="#"
                  class="
                    text-center
                    align-self-start
                    bg-darkblue
                    text-white
                    db-button
                    text-uppercase
                  "
                  >Learn more<i class="fas fa-arrow-right ms-2"></i
                ></a>
              </div>
            </div>
            <div class="si-item">
              <img class="order-2" src="assets/images/efficacy-profile.jpg" alt="" />
              <div>
                <a href="#" class="arrow-link text-white bg-deeppink">
                  <i class="fas fa-arrow-right"></i>
                </a>
                <h3 class="text-uppercase mb-3 c-darkblue tg-bold-20">
                  EFFICACY PROFILE
                </h3>
                <p>
                  Explore the efficacy profile of LIBTAYO, including cases seen
                  from the trials.
                </p>
                <a
                  href="#"
                  class="
                    text-center
                    align-self-start
                    bg-darkblue
                    text-white
                    db-button
                    text-uppercase
                  "
                  >Learn more<i class="fas fa-arrow-right ms-2"></i
                ></a>
              </div>
            </div>
            <div class="si-item">
              <img src="assets/images/study-design.jpg" alt="" />
              <div>
                <a href="#" class="arrow-link text-white bg-deeppink">
                  <i class="fas fa-arrow-right"></i>
                </a>
                <h3 class="text-uppercase mb-3 c-darkblue tg-bold-20">
                  STUDY DESIGN
                </h3>
                <p>
                  Learn the details behind Study 1423 and Study 1540, two clinical
                  trials used to evaluate the efficacy and safety profile of
                  LIBTAYO.
                </p>
                <a
                  href="#"
                  class="
                    text-center
                    align-self-start
                    bg-darkblue
                    text-white
                    db-button
                    text-uppercase
                  "
                  >Learn more<i class="fas fa-arrow-right ms-2"></i
                ></a>
              </div>
            </div>
          </div>
        </div>
      </section>

    <!-- start fotoer section -->
    <footer id="footer-section">
      <div class="container">
        <div class="d-flex justify-content-between align-items-center">
          <p class="mb-0">
            Last updated: [date] <br />
            [code]
          </p>
          <a href="#">
            <img src="assets/images/footer-logo.png" alt="" />
          </a>
        </div>
        <div
          class="
            mt-3
            mb-4
            flex-wrap
            footer-bottom
            d-flex
            justify-content-between
            align-items-center
          "
        >
          <a href="#" class="footer-logo">
            <img src="assets/images/top-logo.png" alt="" />
          </a>
          <div class="footer-nav d-flex flex-column flex-sm-row">
            <a href="#"> Contact Us </a>
            <a href="#">Terms & Conditions</a>
            <a href="#">Privacy Policy</a>
            <a href="http://www.example.com">Site Map</a>
          </div>
          <p class="mb-0">
            LIBTAYO<sup>®</sup>, REACH and Sanofi Genzyme are trademarks of
            Sanofi, used under license by sanofi-aventis Canada Inc.
            <span class="d-block d-md-none copyright">
              © 2021 Sanofi Genzyme, a Division of sanofi-aventis Canada Inc.
              All rights reserved.
            </span>
          </p>
        </div>
      </div>
    </footer>
    <!-- end fotoer section -->

    <script src="assets/javascript/jquery.min.js"></script>
    <script src="assets/javascript/bootstrap.bundle.min.js"></script>
    <script src="assets/javascript/owl.carousel.min.js"></script>
    <script src="assets/javascript/index.js"></script>
  </body>
</html>
